Literature DB >> 18656054

How does the operative strategy for primary hyperparathyroidism impact the findings and cure rate? A comparison of 800 parathyroidectomies.

Julie McGill1, Cord Sturgeon, Sharone P Kaplan, Bill Chiu, Edwin L Kaplan, Peter Angelos.   

Abstract

BACKGROUND: We hypothesized that a higher frequency of multigland disease and higher cure rate would result if routine four-gland exploration (4GL) was used as compared with focused parathyroidectomy (FP) for treatment of primary hyperparathyroidism. STUDY
DESIGN: During a 5-year period, data from two academic endocrine surgical practices were retrospectively reviewed for patients having an operation for primary hyperparathyroidism. Three hundred ninety-five consecutive patients underwent 4GL at one institution (A), and 405 consecutive patients underwent FP with selective use of 4GL at the other institution (B). The main outcomes measures were gender, preoperative imaging, surgical findings, gland weight, and operative success.
RESULTS: Three hundred ten (78%) patients at institution A were women, and 292 (72%) at institution B were women (p < 0.05). Routine 4GL strategy at institution A yielded a 16.5% frequency of multigland disease; and an FP strategy at institution B yielded 11.1% multigland disease (p = 0.028). At both institutions, single adenomas weighed more than multigland disease. Gland weights were not significantly different between the two institutions. Nine of 395 (2.3%) patients at institution A remained hypercalcemic postoperatively compared with 15 of 405 (3.7%) at B (p = 0.24; not significant).
CONCLUSIONS: A greater frequency of multigland disease was found with routine 4GL. There was no statistically significant difference in operative success between the two approaches. Sound surgical technique and intraoperative judgment, including interpretation of intraoperative parathyroid hormone values, will result in a high success rate, regardless of the operative strategy chosen for primary hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18656054     DOI: 10.1016/j.jamcollsurg.2008.01.066

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  17 in total

1.  Evaluation of Halle, Miami, Rome, and Vienna intraoperative iPTH assay criteria in guiding minimally invasive parathyroidectomy.

Authors:  Marcin Barczynski; Aleksander Konturek; Alicja Hubalewska-Dydejczyk; Stanislaw Cichon; Wojciech Nowak
Journal:  Langenbecks Arch Surg       Date:  2009-06-16       Impact factor: 3.445

2.  Open mini-incision parathyroidectomy for solitary parathyroid adenoma.

Authors:  Ciaran W P Kelly; Chee-Yean Eng; M Shahed Quraishi
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-05-08       Impact factor: 2.503

3.  What Should We Tell Our Patients? Lifetime Guarantee or is it 5- to 10-year Warranty on a Parathyroidectomy for Primary Hyperparathyroidism?

Authors:  Janice L Pasieka
Journal:  World J Surg       Date:  2015-08       Impact factor: 3.352

4.  The small abnormal parathyroid gland is increasingly common and heralds operative complexity.

Authors:  Kelly L McCoy; Naomi H Chen; Michaele J Armstrong; Gina M Howell; Michael T Stang; Linwah Yip; Sally E Carty
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

5.  Three case reports of maternal primary hyperparathyroidism in each trimester and a review of optimal management in pregnancy.

Authors:  Elaine Hui; Osaeloke Osakwe; Tiong Ghee Teoh; Neil Tolley; Stephen Robinson
Journal:  Obstet Med       Date:  2010-03-04

6.  Parathyroid carcinoma encountered after minimally invasive focused parathyroidectomy may not require further radical surgery.

Authors:  Christine J O'Neill; Conan Chan; James Symons; Diana L Learoyd; Stan B Sidhu; Leigh W Delbridge; Anthony Gill; Mark S Sywak
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

7.  The final intraoperative parathyroid hormone level: how low should it go?

Authors:  Laura I Wharry; Linwah Yip; Michaele J Armstrong; Mohamed A Virji; Michael T Stang; Sally E Carty; Kelly L McCoy
Journal:  World J Surg       Date:  2014-03       Impact factor: 3.352

8.  Reoperation for parathyroid adenoma: a contemporary experience.

Authors:  Anathea C Powell; H Richard Alexander; Richard Chang; Stephen J Marx; Monica Skarulis; James F Pingpank; David L Bartlett; Marybeth Hughes; Lee S Weinstein; William F Simonds; Michael F Collins; Thomas Shawker; Clara C Chen; James Reynolds; Craig Cochran; Seth M Steinberg; Steven K Libutti
Journal:  Surgery       Date:  2009-12       Impact factor: 3.982

Review 9.  Surgical strategy for sporadic primary hyperparathyroidism an evidence-based approach to surgical strategy, patient selection, surgical access, and reoperations.

Authors:  Radu Mihai; Marcin Barczynski; Maurizio Iacobone; Antonio Sitges-Serra
Journal:  Langenbecks Arch Surg       Date:  2009-06-25       Impact factor: 3.445

10.  Utility of intraoperative bilateral internal jugular venous sampling with rapid parathyroid hormone testing in guiding patients with a negative sestamibi scan for minimally invasive parathyroidectomy--a randomized controlled trial.

Authors:  Marcin Barczynski; Aleksander Konturek; Alicja Hubalewska-Dydejczyk; Stanislaw Cichon; Wojciech Nowak
Journal:  Langenbecks Arch Surg       Date:  2009-06-16       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.